Sergey Vladimirovich Sergiyko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sergey Vladimirovich Sergiyko has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Sergei A. Lukyanov
Department of General and Pediatric Surgery, South Ural State Medical University, Chelyabinsk 454092, Russia
8 shared publications - Sergei Evgenievich Titov
Institute of Molecular and Cellular Biology of the Siberian Branch of the Russian Academy of Sciences; Joint-Stock Company Vector-Best
5 shared publications - T. E. Ilyina
South Ural State Medical University
5 shared publications - Yuliya Andreevna Veryaskina
Institute of Molecular and Cellular Biology of the Siberian Branch of the Russian Academy of Sciences
5 shared publications - Denis V. Korotovskii
Department of General and Pediatric Surgery, South Ural State Medical University, Chelyabinsk 454092, Russia
3 shared publications - Dmitriy S. Zolotukhin
South Ural State Medical University; Chelyabinsk Regional Children's Clinical Hospital
3 shared publications
Latest Publications
- 30 October 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (5)
Prognostic value of the tissue levels microRNA in hepatocellular carcinoma (a pilot study)
Hepatocellular carcinoma (HCC) occupies a leading position among malignant liver tumors, is often characterized by an aggressive course and an unfavorable prognosis for patients. The search for reliable biomarkers capable of predicting individual risk for each patient at early stages, as well as determining a personalized approach to treatment, are key factors influencing patient survival. Objective. Assess the expression of 14 microRNAs in the tumor tissue of patients with HCC, its association with the aggressive course of the disease, BCLC stage, and tumor size. Material and methods. The study included 22 patients with aggressive and non-aggressive HCC, in whom the relative expression level of 14 microRNAs was determined in tissue samples obtained after trepan biopsy or surgical liver resection, as well as the level of AFP in blood plasma. Results. Statistically significant differences between the groups were found for miR-192: the median expression level of miR-192 in the aggressive course group was almost 2 times lower and amounted to -76.9 units (Q1; Q3: –54.8; –34.8) versus –45.5 units (–118.6; –54.2) in the second group (p=0.0083). The area under the ROC curve for miR-192 was 0.87, sensitivity was 81.8%, and specificity was 72.7%, which exceeds the similar indicators for serum AFP (63.6% for both parameters). A moderate negative correlation was found between tumor size and the expression of miR-122 (p=–0.50; p=0.018) and miR-192 (p=–0.45; p=0.036). When comparing BCLC stages (A, B, B3+C), significant differences were obtained for miR-20a (p=0.01), miR-18a (p=0.03), and miR-192 (p=0.03). No statistically significant associations were found for the other microRNAs. Conclusion. The decrease in miR-192 expression is associated with an aggressive course of HCC and has diagnostic value superior to AFP. The negative correlation of miR-122 and miR-192 with tumor size confirms their role as suppressors of tumor growth. The obtained data justify the feasibility of further studying miR-192 and miR-122 as promising biomarkers for stratifying the risk of HCC progression.
- 30 October 2026
- Published by Media Sphere Publishing Group in P.A. Herzen Journal of Oncology
- Vol. 15 (5)
Prognostic value of the tissue levels microRNA in hepatocellular carcinoma (a pilot study)
Hepatocellular carcinoma (HCC) occupies a leading position among malignant liver tumors, is often characterized by an aggressive course and an unfavorable prognosis for patients. The search for reliable biomarkers capable of predicting individual risk for each patient at early stages, as well as determining a personalized approach to treatment, are key factors influencing patient survival. Objective. Assess the expression of 14 microRNAs in the tumor tissue of patients with HCC, its association with the aggressive course of the disease, BCLC stage, and tumor size. Material and methods. The study included 22 patients with aggressive and non-aggressive HCC, in whom the relative expression level of 14 microRNAs was determined in tissue samples obtained after trepan biopsy or surgical liver resection, as well as the level of AFP in blood plasma. Results. Statistically significant differences between the groups were found for miR-192: the median expression level of miR-192 in the aggressive course group was almost 2 times lower and amounted to -76.9 units (Q1; Q3: –54.8; –34.8) versus –45.5 units (–118.6; –54.2) in the second group (p=0.0083). The area under the ROC curve for miR-192 was 0.87, sensitivity was 81.8%, and specificity was 72.7%, which exceeds the similar indicators for serum AFP (63.6% for both parameters). A moderate negative correlation was found between tumor size and the expression of miR-122 (p=–0.50; p=0.018) and miR-192 (p=–0.45; p=0.036). When comparing BCLC stages (A, B, B3+C), significant differences were obtained for miR-20a (p=0.01), miR-18a (p=0.03), and miR-192 (p=0.03). No statistically significant associations were found for the other microRNAs. Conclusion. The decrease in miR-192 expression is associated with an aggressive course of HCC and has diagnostic value superior to AFP. The negative correlation of miR-122 and miR-192 with tumor size confirms their role as suppressors of tumor growth. The obtained data justify the feasibility of further studying miR-192 and miR-122 as promising biomarkers for stratifying the risk of HCC progression.
- Open Access
- 10 July 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (3) , 20-33
The expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review
Gastric cancer is one of the most common and aggressive malignant neoplasms with pronounced geographic heterogeneity. Stage IV disease with cytologic peritoneal carcinomatosis represents a distinct patient population, for whom the primary treatment is palliative systemic antitumor drug therapy without the possibility of surgical intervention under standard conditions. Cytoreductive surgery can reduce tumor burden, subsequently decreasing the risk of disease progression. Currently, clinical guidelines in the Russian Federation, the United States of America, and the European Union present different approaches to the treatment of such patients. Some authors use cytoreductive gastrectomy combined with systemic antitumor therapy, as well as hyperthermic intraperitoneal chemotherapy (HIPEC) and intraperitoneal aerosol chemotherapy (PIPAC), while other studies report conflicting results regarding surgical intervention and favor systemic antitumor therapy alone. There are no reliable data on the effectiveness of cytoreductive intervention for gastric cancer with cytological peritoneal carcinomatosis, either as an independent treatment or as part of combined therapy, which necessitates further research, observation and analysis.
- 10 July 2026
- Published by ECO-Vector LLC (Publications) in Perm Medical Journal
- Vol. 43 (3) , 20-33
Open AccessThe expediency of palliative (cytoreductive) gastrectomy as part of combined treatment for stage IV gastric cancer with cytological peritoneal carcinomatosis (Cy+). A literature review
Gastric cancer is one of the most common and aggressive malignant neoplasms with pronounced geographic heterogeneity. Stage IV disease with cytologic peritoneal carcinomatosis represents a distinct patient population, for whom the primary treatment is palliative systemic antitumor drug therapy without the possibility of surgical intervention under standard conditions. Cytoreductive surgery can reduce tumor burden, subsequently decreasing the risk of disease progression. Currently, clinical guidelines in the Russian Federation, the United States of America, and the European Union present different approaches to the treatment of such patients. Some authors use cytoreductive gastrectomy combined with systemic antitumor therapy, as well as hyperthermic intraperitoneal chemotherapy (HIPEC) and intraperitoneal aerosol chemotherapy (PIPAC), while other studies report conflicting results regarding surgical intervention and favor systemic antitumor therapy alone. There are no reliable data on the effectiveness of cytoreductive intervention for gastric cancer with cytological peritoneal carcinomatosis, either as an independent treatment or as part of combined therapy, which necessitates further research, observation and analysis.
- 3 April 2024
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery
- Vol. 28 (1) , 26-32
Comparison of laser ablation and Karidakis surgery for treating epithelial coccygeal passages
BACKGROUND: Laser ablation is a technique which was originally used to treat various cystic and fistulous structures. Due to promising results, surgeons began to use diode lasers to treat pilonidal cysts. The authors developed their own technique of ultrasonic-guided laser ablation in patients with the discussed pathology. AIM: To compare outcomes after laser ablation and Karidakis surgery for treating pilonidal cysts. METHODS: A prospective non-randomized comparative study was performed. Outcomes of surgical interventions were analyzed in 71 patient with pilonidal disease: 24 patients were operated with laser obliteration technique and 47 — with Karidakis technique. The researchers compared: time of wound healing and number of recurrences, complications, length of hospital stay and duration of postoperative pain. RESULTS: Mean operative time in the laser group was 26.45±5.41 min (20–35 min), while in the Karidakis group — 58.63±7.42 min (50–75 min). In the laser group, primary healing was registered in 23 out of 24 patients (95.8%) with an overall complication rate 20.83%. In each group, there were registered two cases with relapses after discharge. The obtained clinical results, in general, were comparable to those in the world literature. However, the quality of life of patients after laser treatment was significantly better than after traditional surgical intervention which is confirmed by less hospital stay up to 5–7 bed-days; by less surgical time, in average, 25 minutes; faster recovery — within one week after surgery; faster return to everyday life, as well as less pain syndrome in the postoperative period. CONCLUSION: Laser ablation of the coccygeal tract is comparable to Karidakis surgery in terms of wound healing and recurrences, but it gives better results in terms of surgical time, hospital stay and postoperative pain.
- 3 April 2024
- Published by ECO-Vector LLC in Russian Journal of Pediatric Surgery
- Vol. 28 (1) , 26-32
Comparison of laser ablation and Karidakis surgery for treating epithelial coccygeal passages
BACKGROUND: Laser ablation is a technique which was originally used to treat various cystic and fistulous structures. Due to promising results, surgeons began to use diode lasers to treat pilonidal cysts. The authors developed their own technique of ultrasonic-guided laser ablation in patients with the discussed pathology. AIM: To compare outcomes after laser ablation and Karidakis surgery for treating pilonidal cysts. METHODS: A prospective non-randomized comparative study was performed. Outcomes of surgical interventions were analyzed in 71 patient with pilonidal disease: 24 patients were operated with laser obliteration technique and 47 — with Karidakis technique. The researchers compared: time of wound healing and number of recurrences, complications, length of hospital stay and duration of postoperative pain. RESULTS: Mean operative time in the laser group was 26.45±5.41 min (20–35 min), while in the Karidakis group — 58.63±7.42 min (50–75 min). In the laser group, primary healing was registered in 23 out of 24 patients (95.8%) with an overall complication rate 20.83%. In each group, there were registered two cases with relapses after discharge. The obtained clinical results, in general, were comparable to those in the world literature. However, the quality of life of patients after laser treatment was significantly better than after traditional surgical intervention which is confirmed by less hospital stay up to 5–7 bed-days; by less surgical time, in average, 25 minutes; faster recovery — within one week after surgery; faster return to everyday life, as well as less pain syndrome in the postoperative period. CONCLUSION: Laser ablation of the coccygeal tract is comparable to Karidakis surgery in terms of wound healing and recurrences, but it gives better results in terms of surgical time, hospital stay and postoperative pain.
- 15 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 41 (1) , 90-107
Clinical and morphological features and unsolved issues in diagnosis of aggressive forms of papillary thyroid carcinoma
Differentiated thyroid cancer (DTC) is a disease with a favorable clinical course and high survival rate compared to other epithelial tumors. The majority of DTC (up to 85 %) is represented by various subtypes of papillary thyroid cancer (PTC). Aggressive forms of PTC characterized by early lymphogenous and hematogenous metastasis, low avidity to radioiodine therapy (RIT), low relapse-free survival rates and high mortality rate compared to other types of PTC occur among them. Preoperative diagnosis of PTC is based on the results of ultrasound (US) examination and fine-needle aspiration biopsy (FNA) with cytological examination of the aspirate. At the same time, the capabilities of cytological examination in determining the histological type of PTC are limited and it does not allow to predict its aggressiveness and plan adequate treatment. Molecular genetic tests of the tumor cytological and morphological material are effective in prognosis of aggressiveness of PTC due to the determination of specific mutations in the BRAF, TERT, RAS genes and the quantitative expression of oncogenic and tumor suppressive microRNAs. Some of these indicators are already used in the morphological classification of tumors of the endocrine system. At the same time, there are contradictory data concerning the connection of the molecular genetic portrait of PTC, the clinical manifestations of its aggressiveness (extrathyroidal invasion, early metastasis, and radioiodine resistance) and its pathomorphological structure. We tried to summarize and analyze the literature data regarding the diagnosis of aggressive variants of PTC.
- 15 January 2024
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 41 (1) , 90-107
Clinical and morphological features and unsolved issues in diagnosis of aggressive forms of papillary thyroid carcinoma
Differentiated thyroid cancer (DTC) is a disease with a favorable clinical course and high survival rate compared to other epithelial tumors. The majority of DTC (up to 85 %) is represented by various subtypes of papillary thyroid cancer (PTC). Aggressive forms of PTC characterized by early lymphogenous and hematogenous metastasis, low avidity to radioiodine therapy (RIT), low relapse-free survival rates and high mortality rate compared to other types of PTC occur among them. Preoperative diagnosis of PTC is based on the results of ultrasound (US) examination and fine-needle aspiration biopsy (FNA) with cytological examination of the aspirate. At the same time, the capabilities of cytological examination in determining the histological type of PTC are limited and it does not allow to predict its aggressiveness and plan adequate treatment. Molecular genetic tests of the tumor cytological and morphological material are effective in prognosis of aggressiveness of PTC due to the determination of specific mutations in the BRAF, TERT, RAS genes and the quantitative expression of oncogenic and tumor suppressive microRNAs. Some of these indicators are already used in the morphological classification of tumors of the endocrine system. At the same time, there are contradictory data concerning the connection of the molecular genetic portrait of PTC, the clinical manifestations of its aggressiveness (extrathyroidal invasion, early metastasis, and radioiodine resistance) and its pathomorphological structure. We tried to summarize and analyze the literature data regarding the diagnosis of aggressive variants of PTC.
- Open Access
- 11 December 2023
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 13 (3) , 10-23
Problems of follicular thyroid carcinoma diagnostics
Introduction. Follicular thyroid cancer is much less common than papillary cancer. Nevertheless, the main difficulties in preoperative diagnosis are associated with this morphological type. A fine needle aspiration biopsy is not able to distinguish a benign follicular adenoma from a follicular carcinoma, which forces surgeons to perform diagnostic resection of the thyroid gland in all patients with a cytological conclusion «follicular tumor».Aim. To search for microRNAs specific to follicular cancer by sequencing a new generation.Materials and methods. The data of patients with a preoperative cytological conclusion «follicular tumor» operated at the Chelyabinsk Center for Endocrine Surgery from 2021 to 2022 were analyzed. Histological preparations were reviewed twice by pathologists. Genome sequencing was performed in 8 histological samples of follicular cancer and 8 samples of follicular adenoma. The expression levels of the selected microRNAs were compared with 198 archived cytological samples of various types of thyroid tumors.Results. The risk of malignancy at the cytological conclusion «follicular tumor» was 25.4 % (error 74.6 %). Follicular cancer was first detected in 36 patients, the incidence was 0.68 new cases per 100 thousand population per year. The diagnosis of «follicular cancer» was confirmed by 3 morphologists in 8 (36.4 %) cases. Sequencing revealed the 5 most distinct microRNAs between follicular cancer and follicular adenoma: miR-625, miR-323a, let-7a, let-7c and miR-574. The level of errors in the differentiation of follicular adenoma and follicular cancer using the microRNAs we selected was 21 % (35 % with cross-validation).Conclusion. Molecular genetic research at the preoperative stage, aimed at differentiating follicular cancer and follicular adenoma, in comparison with cytological research has a greater, but insufficient accuracy for making a final clinical decision.
- 11 December 2023
- Published by Publishing House ABV Press in Head and Neck Tumors (HNT)
- Vol. 13 (3) , 10-23
Open AccessProblems of follicular thyroid carcinoma diagnostics
Introduction. Follicular thyroid cancer is much less common than papillary cancer. Nevertheless, the main difficulties in preoperative diagnosis are associated with this morphological type. A fine needle aspiration biopsy is not able to distinguish a benign follicular adenoma from a follicular carcinoma, which forces surgeons to perform diagnostic resection of the thyroid gland in all patients with a cytological conclusion «follicular tumor».Aim. To search for microRNAs specific to follicular cancer by sequencing a new generation.Materials and methods. The data of patients with a preoperative cytological conclusion «follicular tumor» operated at the Chelyabinsk Center for Endocrine Surgery from 2021 to 2022 were analyzed. Histological preparations were reviewed twice by pathologists. Genome sequencing was performed in 8 histological samples of follicular cancer and 8 samples of follicular adenoma. The expression levels of the selected microRNAs were compared with 198 archived cytological samples of various types of thyroid tumors.Results. The risk of malignancy at the cytological conclusion «follicular tumor» was 25.4 % (error 74.6 %). Follicular cancer was first detected in 36 patients, the incidence was 0.68 new cases per 100 thousand population per year. The diagnosis of «follicular cancer» was confirmed by 3 morphologists in 8 (36.4 %) cases. Sequencing revealed the 5 most distinct microRNAs between follicular cancer and follicular adenoma: miR-625, miR-323a, let-7a, let-7c and miR-574. The level of errors in the differentiation of follicular adenoma and follicular cancer using the microRNAs we selected was 21 % (35 % with cross-validation).Conclusion. Molecular genetic research at the preoperative stage, aimed at differentiating follicular cancer and follicular adenoma, in comparison with cytological research has a greater, but insufficient accuracy for making a final clinical decision.
- Open Access
- 21 August 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 17 (3) , 4-5
Prospects of using the microRNA expression level and parameters of nucleolar organizer regions in the choice of surgical tactics for follicular thyroid tumor of uncertain malignant potential
BACKGROUND: According to modern concepts [1], microRNAs modulate the expression of eukaryotic genes with different oncogenetic directions of action. according to the data from the scientifi literature [2–4], microRNA-146b, -199b can be used for typing thyroid neoplasms, -221, -223, -31, -375, -451a, -551b, etc. Nucleolar organizers (NOR) are sections of chromosomes that form a nucleolus inside the cell nucleus [5–7]. The condition of the regions of nucleolar ribosome organizers (AgNORs) is a marker of the rate of cell proliferation, since they are involved in the regulation of the mitotic cycle [8], and in thyroid pathology [9].AIM: To evaluate the diagnostic significance of the level of expression of some microRNAs and the number of regions of nucleolar organizers in thyroid tissue in the case of follicular thyroid tumor of uncertain malignant potential (FT-UMP) to objectify approaches to the validity of the chosen surgical tactics.MATERIALS AND METHODS: In our study of 3960 patients with surgery due to various thyroidopathies in 2018–2021 on the basis of the thyroid center of Chelyabinsk. 2063 patients were operated on for tumor pathology. In this group, in 98 cases (the study group), FT-UMP was diagnosed based on morphological criteria of neoplasm [10]. This accounted for 4.75% of all surgical tumor pathology during this time. The study group studied the profile, the level of microRNA expression by real-time PCR and the regions of nucleolar organizers in 98 cases of FT-UMP, which amounted to 4.75% of all those operated for thyroid tumors over four years.RESULTS: In 29 (29.6%) cases, a microRNA spectrum characteristic of malignant neoplasms was registered in the tumor tissue. In the remaining 69 (70.4%) cases out of 98 observations, the spectrum and level of microRNA expression corresponded to follicular adenoma. Statistically significant differences in the average number of AgNORs and the ratio between the cell area and the number of AgNORs granules were revealed within the formed subgroups. The study found that an increase in the average number of AgNORs and the ratio of the core area to the number of silver nitrate granules in the 2nd subgroup relative to the 1st, as well as the presence of type II cells indicates the appearance of proliferating tumor cells in the neoplasm and can be considered as prognostic criteria for tumor malignancy. These results are consistent with the obtained indicators of molecular genetic research CONCLUSION: The data can serve as additional criteria for assessing the proliferative activity of the follicular epithelium in thyroid neoplasia. Including clarifying the potential of malignancy. The conditionally malignant variant diagnosed before the operation will justify the need and scope of surgical intervention, and when identifying a set of criteria for conditionally benign HPV, it can be recommended to adhere to wait-and-see tactics.
- 21 August 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 17 (3) , 4-5
Open AccessProspects of using the microRNA expression level and parameters of nucleolar organizer regions in the choice of surgical tactics for follicular thyroid tumor of uncertain malignant potential
BACKGROUND: According to modern concepts [1], microRNAs modulate the expression of eukaryotic genes with different oncogenetic directions of action. according to the data from the scientifi literature [2–4], microRNA-146b, -199b can be used for typing thyroid neoplasms, -221, -223, -31, -375, -451a, -551b, etc. Nucleolar organizers (NOR) are sections of chromosomes that form a nucleolus inside the cell nucleus [5–7]. The condition of the regions of nucleolar ribosome organizers (AgNORs) is a marker of the rate of cell proliferation, since they are involved in the regulation of the mitotic cycle [8], and in thyroid pathology [9].AIM: To evaluate the diagnostic significance of the level of expression of some microRNAs and the number of regions of nucleolar organizers in thyroid tissue in the case of follicular thyroid tumor of uncertain malignant potential (FT-UMP) to objectify approaches to the validity of the chosen surgical tactics.MATERIALS AND METHODS: In our study of 3960 patients with surgery due to various thyroidopathies in 2018–2021 on the basis of the thyroid center of Chelyabinsk. 2063 patients were operated on for tumor pathology. In this group, in 98 cases (the study group), FT-UMP was diagnosed based on morphological criteria of neoplasm [10]. This accounted for 4.75% of all surgical tumor pathology during this time. The study group studied the profile, the level of microRNA expression by real-time PCR and the regions of nucleolar organizers in 98 cases of FT-UMP, which amounted to 4.75% of all those operated for thyroid tumors over four years.RESULTS: In 29 (29.6%) cases, a microRNA spectrum characteristic of malignant neoplasms was registered in the tumor tissue. In the remaining 69 (70.4%) cases out of 98 observations, the spectrum and level of microRNA expression corresponded to follicular adenoma. Statistically significant differences in the average number of AgNORs and the ratio between the cell area and the number of AgNORs granules were revealed within the formed subgroups. The study found that an increase in the average number of AgNORs and the ratio of the core area to the number of silver nitrate granules in the 2nd subgroup relative to the 1st, as well as the presence of type II cells indicates the appearance of proliferating tumor cells in the neoplasm and can be considered as prognostic criteria for tumor malignancy. These results are consistent with the obtained indicators of molecular genetic research CONCLUSION: The data can serve as additional criteria for assessing the proliferative activity of the follicular epithelium in thyroid neoplasia. Including clarifying the potential of malignancy. The conditionally malignant variant diagnosed before the operation will justify the need and scope of surgical intervention, and when identifying a set of criteria for conditionally benign HPV, it can be recommended to adhere to wait-and-see tactics.
- Open Access
- 2 June 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 17 (2) , 29-36
Difficulties and missteps of diagnosis and surgical treatment of patient with multifocal metachronic carcinoma associated with primary hyperparathyroidism
We present a clinical case of a patient with metachronous primary multiple carcinoma of left kidney (2004) with left adrenal metastasis (2021), occult low-grade follicular thyroid carcinoma with lateral neck lymph node metastasis (2019), central lung cancer (2020), primary hyperparathyroidism with coherent parathyroid adenomas with intrathyroid and typical location.Patient had undergone left-side nephrectomy with bilateral adrenalectomy, double-staged thyroidectomy with parathyroidectomy and selective lateral neck dissection and right-side pulmonectomy with 4 sessions of chemotherapy. Almost 20 years after first operation patient has no signs of tumors recurrence. In addition, patient is undergoing hormone replacement therapy (HRT) of adrenal insufficiency and thyroid hormone suppression therapy.This case represents combination of non-hereditary endocrine neoplasms with multiple carcinomas. It also examples mistakes and difficulties of differential diagnosis of primary adrenal tumors and adrenal metastasis.
- 2 June 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 17 (2) , 29-36
Open AccessDifficulties and missteps of diagnosis and surgical treatment of patient with multifocal metachronic carcinoma associated with primary hyperparathyroidism
We present a clinical case of a patient with metachronous primary multiple carcinoma of left kidney (2004) with left adrenal metastasis (2021), occult low-grade follicular thyroid carcinoma with lateral neck lymph node metastasis (2019), central lung cancer (2020), primary hyperparathyroidism with coherent parathyroid adenomas with intrathyroid and typical location.Patient had undergone left-side nephrectomy with bilateral adrenalectomy, double-staged thyroidectomy with parathyroidectomy and selective lateral neck dissection and right-side pulmonectomy with 4 sessions of chemotherapy. Almost 20 years after first operation patient has no signs of tumors recurrence. In addition, patient is undergoing hormone replacement therapy (HRT) of adrenal insufficiency and thyroid hormone suppression therapy.This case represents combination of non-hereditary endocrine neoplasms with multiple carcinomas. It also examples mistakes and difficulties of differential diagnosis of primary adrenal tumors and adrenal metastasis.
- Open Access
- 30 April 2023
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 22 (2) , 74-83
Predictive assessment of micro RNA expression level and number of nucleolar organizer regions with follicular thyroid tumor of undetermined malignant potential
Introduction This article presents the current views on follicular thyroid tumor of undetermined malignant potential (FTUMP) taking into account the principles of WHO classification. Molecular genetic study with identification of mutation of some genes as well as determination of expression level of some microRNAs are given as methods for detection of potential predictors of oncodiagnostics. It was shown that the state of nucleus organizer regions is a marker of cell proliferation rate.The aim of the investigation was to estimate prognostic significance of expression level of some microRNAs and amount of regions of the nucleus organizers in the thyroid tissue at FTUMP to objectify approaches to development of adequate surgical tactics.Materials and methods Profile, microRNA expression level by real time PCR and regions of the nucleus organizers were studied in 98 cases of FTUMP which made up 4.75% of all cases of thyroid tumors operated on during four years.Results In 29 (29.6%) cases the spectrum of microRNA typical for malignant neoplasms was registered in the tissue of the FTUMP. In the remaining 69 (70.4%) cases out of 98 observations the spectrum and the expression level of microRNA corresponded to the follicular adenoma. Statistically significant differences in the average number of AgNORs and correlation between the cell area and the number of AgNORs granules were found within the formed subgroups.Discussion Increase of the mean number of AgNORs and the ratio of the nucleus area to the number of silver nitrate granules in the 2nd subgroup in comparison with the 1st one, as well as the appearance of the type II cells testifies to the appearance of the proliferating tumor cells in a new tumor growth and can be considered as prognostic criteria of tumor malignization. These results correlate with the findings of molecular-genetic study. Conclusion The data of the literature and the results obtained by studying the profile and the expression level of a number of microRNAs, morphometric characteristics and counting of thyrocyte nucleus organizer regions may serve as additional criteria for evaluation of the proliferative activity of the follicular epithelium in thyroid neoplasms, in particular to clarify the malignancy potential. Preoperatively diagnosed conditionally malignant FTUMP will allow to justify the necessity and amount of surgical intervention, and if a complex of criteria of conditionally benign FTUMP is revealed, to stick to the waiting tactics and refuse surgical intervention.
- 30 April 2023
- Published by Ural State Medical University in Ural Medical Journal
- Vol. 22 (2) , 74-83
Open AccessPredictive assessment of micro RNA expression level and number of nucleolar organizer regions with follicular thyroid tumor of undetermined malignant potential
Introduction This article presents the current views on follicular thyroid tumor of undetermined malignant potential (FTUMP) taking into account the principles of WHO classification. Molecular genetic study with identification of mutation of some genes as well as determination of expression level of some microRNAs are given as methods for detection of potential predictors of oncodiagnostics. It was shown that the state of nucleus organizer regions is a marker of cell proliferation rate.The aim of the investigation was to estimate prognostic significance of expression level of some microRNAs and amount of regions of the nucleus organizers in the thyroid tissue at FTUMP to objectify approaches to development of adequate surgical tactics.Materials and methods Profile, microRNA expression level by real time PCR and regions of the nucleus organizers were studied in 98 cases of FTUMP which made up 4.75% of all cases of thyroid tumors operated on during four years.Results In 29 (29.6%) cases the spectrum of microRNA typical for malignant neoplasms was registered in the tissue of the FTUMP. In the remaining 69 (70.4%) cases out of 98 observations the spectrum and the expression level of microRNA corresponded to the follicular adenoma. Statistically significant differences in the average number of AgNORs and correlation between the cell area and the number of AgNORs granules were found within the formed subgroups.Discussion Increase of the mean number of AgNORs and the ratio of the nucleus area to the number of silver nitrate granules in the 2nd subgroup in comparison with the 1st one, as well as the appearance of the type II cells testifies to the appearance of the proliferating tumor cells in a new tumor growth and can be considered as prognostic criteria of tumor malignization. These results correlate with the findings of molecular-genetic study. Conclusion The data of the literature and the results obtained by studying the profile and the expression level of a number of microRNAs, morphometric characteristics and counting of thyrocyte nucleus organizer regions may serve as additional criteria for evaluation of the proliferative activity of the follicular epithelium in thyroid neoplasms, in particular to clarify the malignancy potential. Preoperatively diagnosed conditionally malignant FTUMP will allow to justify the necessity and amount of surgical intervention, and if a complex of criteria of conditionally benign FTUMP is revealed, to stick to the waiting tactics and refuse surgical intervention.
- Open Access
- 19 January 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 16 (1) , 23-28
Pheochromocytoma with paraneoplastic phenomena manifested as myelodysplastic syndrome
We present a clinical case of 22yo patient with diagnosis of pheochoromocytoma complicated with myelodysplastic syndrome as manifestation of paraneoplastic phenomenon. The onset of the disease displays typical clinical picture of pheochromacytoma. After medical examination and survey it was discovered a tumor in left adrenal gland and elevation of metanephrines and normetanephrines. In addition, patient has severe anemia and thrombocytopenia. Sternal punction with morphological examination and immunophenotyping were performed. Patient had consulted by hematologist. After all additional analysis cause of anemia and thrombocytopenia remained unknown and related to presence of tumor.Patient was performed a long-time and vast pre-operative preparation with administration of doxazosin and transfusions of blood and platelet concentrate. In continuation, mass in left adrenal gland was excised with spleen by thoracophrenolaparotomy. Morphology confirmed pheochromacytoma, which has typical histological structure and circulatory disorders. Spleen has no specifical features except of focuses of extramedullar hematopoiesis. Patient has short period of hormone therapy to avoid adrenal crisis on post-operative stage. Also massive transfutions of blood and platelet concentrate was performed due to persisting anemia and thrombocytopenia. There were no manifestations of hemorrhage syndrome after the surgery. Myelodysplastic syndrome was detected 3 month later and manifested itself in form of refractory anemia and severe thrombocytopenia, which persisted for long period and required corrections with therapy and transfusions. Only through 5-year observation after adrenalectomy patient has positive dynamic and leveling of laboratory tests without symptoms of myelodysplastic syndrome.
- 19 January 2023
- Published by Endocrinology Research Centre in Endocrine Surgery
- Vol. 16 (1) , 23-28
Open AccessPheochromocytoma with paraneoplastic phenomena manifested as myelodysplastic syndrome
We present a clinical case of 22yo patient with diagnosis of pheochoromocytoma complicated with myelodysplastic syndrome as manifestation of paraneoplastic phenomenon. The onset of the disease displays typical clinical picture of pheochromacytoma. After medical examination and survey it was discovered a tumor in left adrenal gland and elevation of metanephrines and normetanephrines. In addition, patient has severe anemia and thrombocytopenia. Sternal punction with morphological examination and immunophenotyping were performed. Patient had consulted by hematologist. After all additional analysis cause of anemia and thrombocytopenia remained unknown and related to presence of tumor.Patient was performed a long-time and vast pre-operative preparation with administration of doxazosin and transfusions of blood and platelet concentrate. In continuation, mass in left adrenal gland was excised with spleen by thoracophrenolaparotomy. Morphology confirmed pheochromacytoma, which has typical histological structure and circulatory disorders. Spleen has no specifical features except of focuses of extramedullar hematopoiesis. Patient has short period of hormone therapy to avoid adrenal crisis on post-operative stage. Also massive transfutions of blood and platelet concentrate was performed due to persisting anemia and thrombocytopenia. There were no manifestations of hemorrhage syndrome after the surgery. Myelodysplastic syndrome was detected 3 month later and manifested itself in form of refractory anemia and severe thrombocytopenia, which persisted for long period and required corrections with therapy and transfusions. Only through 5-year observation after adrenalectomy patient has positive dynamic and leveling of laboratory tests without symptoms of myelodysplastic syndrome.
- 10 November 2022
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 39 (5) , 80-92
Post-transcriptional micro-RNAs in diagnostics and personalization of treatment in patients with thyroid tumors: literary review
Among the unsolved problems in the treatment of patients with nodular thyroid pathology, there is a large number of diagnostic operations associated with difficulties in cytological diagnostics of follicular neoplasia, limited by opportunities in preoperative assessment of the malignant potential of thyroid cancer. A decrease in the effectiveness of targeted therapy in patients with radioiodresistant thyroid cancer occurs due to the ability of the tumor to activate parallel proliferative signaling pathways. It is assumed that the key to solving these problems lies in understanding various genetic changes in the tumor cell, such as point mutations, insertions and deletions, gene merges, rearrangements or gene translocations. A special place in this list is occupied by microRNAs. It is a class of small non-coding RNAs, which regulate post-transcriptional gene expression and thereby participate in cell differentiation, proliferation, angiogenesis, apoptosis resistance and activation of thyroid cancer metastasis. This review contains information about microRNAs detected in various types of thyroid tumors of diagnostic, prognostic and therapeutic interest. While some of them have been introduced into routine practice, others are new and require additional research before clinical use.
- 10 November 2022
- Published by ECO-Vector LLC in Perm Medical Journal
- Vol. 39 (5) , 80-92
Post-transcriptional micro-RNAs in diagnostics and personalization of treatment in patients with thyroid tumors: literary review
Among the unsolved problems in the treatment of patients with nodular thyroid pathology, there is a large number of diagnostic operations associated with difficulties in cytological diagnostics of follicular neoplasia, limited by opportunities in preoperative assessment of the malignant potential of thyroid cancer. A decrease in the effectiveness of targeted therapy in patients with radioiodresistant thyroid cancer occurs due to the ability of the tumor to activate parallel proliferative signaling pathways. It is assumed that the key to solving these problems lies in understanding various genetic changes in the tumor cell, such as point mutations, insertions and deletions, gene merges, rearrangements or gene translocations. A special place in this list is occupied by microRNAs. It is a class of small non-coding RNAs, which regulate post-transcriptional gene expression and thereby participate in cell differentiation, proliferation, angiogenesis, apoptosis resistance and activation of thyroid cancer metastasis. This review contains information about microRNAs detected in various types of thyroid tumors of diagnostic, prognostic and therapeutic interest. While some of them have been introduced into routine practice, others are new and require additional research before clinical use.